Fingerprint
Dive into the research topics of 'A prospective trial of midwest breast cancer patients: A p53 gene mutation is the most important predictor of adverse outcome'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A prospective trial of midwest breast cancer patients: A p53 gene mutation is the most important predictor of adverse outcome
Hagen Blaszyk, Arndt Hartmann, Julie M. Cunningham, Daniel Schaid, Lester E. Wold, John S. Kovach, Steve S. Sommer
Research output: Contribution to journal › Article › peer-review
42
Scopus
citations